203 related articles for article (PubMed ID: 7809510)
41. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors.
Rorke LB
J Neuropathol Exp Neurol; 1983 Jan; 42(1):1-15. PubMed ID: 6296325
[TBL] [Abstract][Full Text] [Related]
42. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma.
Vortmeyer AO; Stavrou T; Selby D; Li G; Weil RJ; Park WS; Moon YW; Chandra R; Goldstein AM; Zhuang Z
Cancer; 1999 Jun; 85(12):2662-7. PubMed ID: 10375116
[TBL] [Abstract][Full Text] [Related]
43. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
[TBL] [Abstract][Full Text] [Related]
44. Medulloblastoma with cartilaginous differentiation.
Anwer UE; Smith TW; DeGirolami U; Wilkinson HA
Arch Pathol Lab Med; 1989 Jan; 113(1):84-8. PubMed ID: 2910231
[TBL] [Abstract][Full Text] [Related]
45. Localization of the neuronal class III beta-tubulin isotype in foci of early neuritogenesis supports divergent neuroblastic differentiation potential in Wilms' tumors.
Katsetos CD; Nakahara C; Agamanolis DP; Karkavelas G; Lebenthal E; Frankfurter A
Arch Pathol Lab Med; 1994 Oct; 118(10):1002-6. PubMed ID: 7944883
[TBL] [Abstract][Full Text] [Related]
46. Medulloblastomas in late middle age and the elderly: report of 2 cases.
Ramsay DA; Bonnin J; MacDonald DR; Assis L
Clin Neuropathol; 1995; 14(6):337-42. PubMed ID: 8605740
[TBL] [Abstract][Full Text] [Related]
47. Contributions of immunohistochemistry to the problem of differentiation in medulloblastoma.
Giordana MT; Mauro A; Migheli A; Schiffer D
Ital J Neurol Sci; 1983 Dec; 4(4):411-5. PubMed ID: 6674239
[TBL] [Abstract][Full Text] [Related]
48. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
Gajjar A; Hernan R; Kocak M; Fuller C; Lee Y; McKinnon PJ; Wallace D; Lau C; Chintagumpala M; Ashley DM; Kellie SJ; Kun L; Gilbertson RJ
J Clin Oncol; 2004 Mar; 22(6):984-93. PubMed ID: 14970185
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
50. Medulloblastomas with extensive posttherapy neuronal maturation. Report of two cases.
Cai DX; Mafra M; Schmidt RE; Scheithauer BW; Park TS; Perry A
J Neurosurg; 2000 Aug; 93(2):330-4. PubMed ID: 10930022
[TBL] [Abstract][Full Text] [Related]
51. Glial differentiation in medulloblastomas. Histogenetic insight, glial reaction, or invasion of brain?
Coffin CM; Mukai K; Dehner LP
Am J Surg Pathol; 1983 Sep; 7(6):555-65. PubMed ID: 6353953
[TBL] [Abstract][Full Text] [Related]
52. Morphological investigations on cerebellar "neuroblastoma" group.
Yagishita S; Itoh Y; Chiba Y; Kuwana N
Acta Neuropathol; 1982; 56(1):22-8. PubMed ID: 7064656
[TBL] [Abstract][Full Text] [Related]
53. Differential localization of class III, beta-tubulin isotype and calbindin-D28k defines distinct neuronal types in the developing human cerebellar cortex.
Katsetos CD; Frankfurter A; Christakos S; Mancall EL; Vlachos IN; Urich H
J Neuropathol Exp Neurol; 1993 Nov; 52(6):655-66. PubMed ID: 8229085
[TBL] [Abstract][Full Text] [Related]
54. Regulatory peptides in neuronal neoplasms of the central nervous system.
Giangaspero F; Burger PC; Budwit DA; Usellini L; Mancini AM
Clin Neuropathol; 1985; 4(3):111-5. PubMed ID: 2861927
[TBL] [Abstract][Full Text] [Related]
55. The prognostic significance of glial fibrillary acidic protein staining in medulloblastoma.
Goldberg-Stern H; Gadoth N; Stern S; Cohen IJ; Zaizov R; Sandbank U
Cancer; 1991 Aug; 68(3):568-73. PubMed ID: 2065277
[TBL] [Abstract][Full Text] [Related]
56. Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans.
Pöschl J; Lorenz A; Hartmann W; von Bueren AO; Kool M; Li S; Peraud A; Tonn JC; Herms J; Xiang M; Rutkowski S; Kretzschmar HA; Schüller U
Oncogene; 2011 Nov; 30(47):4721-30. PubMed ID: 21602885
[TBL] [Abstract][Full Text] [Related]
57. [Histologic diagnosis and nosologic placement of so-called "cerebellar neuroblastoma" - - with special reference to its relationship to medulloblastomas].
Kurisaka M; Pearl GS; Takei Y
Neurol Med Chir (Tokyo); 1981 Mar; 21(3):295-302. PubMed ID: 6166885
[No Abstract] [Full Text] [Related]
58. Neuronal differentiation associated with Gli3 expression predicts favorable outcome for patients with medulloblastoma.
Miyahara H; Natsumeda M; Yoshimura J; Ogura R; Okazaki K; Toyoshima Y; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2014 Feb; 34(1):1-10. PubMed ID: 23889567
[TBL] [Abstract][Full Text] [Related]
59. [Extraneural metastasis in cerebellar medulloblastomas--report of two cases and review of the literature (author's transl)].
Tamura M; Kawafuchi J; Ishida Y; Hori S; Fukamachi A; Wakao T
Neurol Med Chir (Tokyo); 1980 Mar; 20(3):257-64. PubMed ID: 6155635
[No Abstract] [Full Text] [Related]
60. [Cerebellar medulloblastoma in a 65-year old patient].
Kroh H; Kostkiewicz B
Neurol Neurochir Pol; 1993; 27(5):757-65. PubMed ID: 8115001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
